KALARIS THERAPEUTICS, INC. Accrued Liabilities, Current
KALARIS THERAPEUTICS, INC. (KLRS) had Accrued Liabilities, Current of $4.99 million as of 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-03-07
- 2024-12-31: Accrued Liabilities, Current $4.99M.
- 2024-09-30: Accrued Liabilities, Current $1.36M.
- 2024-06-30: Accrued Liabilities, Current $1.58M.
- 2024-03-31: Accrued Liabilities, Current $4.60M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2024-12-31 | $4.99M 10-K · filed 2025-03-07 |
| 2024-09-30 | $1.36M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.58M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $4.60M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $10.09M 10-K · filed 2025-03-07 |
| 2023-09-30 | $15.92M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $16.73M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $12.29M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $13.98M 10-K · filed 2024-03-15 |
| 2022-09-30 | $13.68M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $13.12M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $10.08M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $20.15M 10-K · filed 2023-02-15 |
| 2021-09-30 | $15.80M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $9.97M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $7.88M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $7.53M 10-K · filed 2022-02-10 |
| 2020-09-30 | $7.85M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $4.55M 10-Q · filed 2020-09-02 |
| 2019-12-31 | $5.16M 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |